Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Use of Intravenous Iron Sucrose to Maintain Haemoglobin Levels and Delay the Onset of Use of Erythropoietic Agents and/or Dialysis in Stage 3/4 Chronic Kidney Disease

NCT00202345 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT00202345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00202345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Use of Intravenous Iron Sucrose to Maintain Haemoglobin Levels and Delay the Onset of Use of Erythropoietic Agents and/or Dialysis in Stage 3/4 Chronic Kidney Disease
Lead sponsor
Melbourne Health
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
February 28, 2007
Enrollment
120
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, kidney failure